Chapter 5: Genetic and Congenital Disorders – Causes & Mechanisms

Welcome to Last Minute Lecture.

This free chapter overview is designed to help students review and understand key concepts.

These summaries supplement not replaced the original textbook and may not be redistributed or resold.

For complete coverage, always consult the official text.

Welcome back to The Deep Dive.

Today, we're tackling a really significant topic, congenital defects.

These are abnormalities that are there right at birth.

And the numbers,

well, really speak for themselves.

We're talking over 185 ,000 infants affected each year just in the U .S.

Yeah, it's a major area.

And sadly, the leading cause of infant death.

Exactly.

So, this isn't just about listing conditions.

We really need to dig into why these happen right at the start of development.

Absolutely.

And that's our mission for this Deep Dive.

We want to help you understand the science behind it all based on our source material.

We'll break it down into three main areas.

Okay.

First, the genetic and chromosomal disorders, the blueprint issues, you could say.

Second, how the environment plays a role.

And third, how we diagnose these conditions in council families.

Got it.

So, let's start with that first pillar, the genetics.

Now, most people have a basic idea of inheritance, right?

Genes, parents, passing things down.

Sure, the basic.

But when you actually get into it, especially with things like autosomal dominant disorders, where you supposedly only need one faulty gene, it gets tricky.

Like, why do some conditions seem to skip a generation sometimes?

How does that work?

That is a perfect question to kick things off.

Because it really highlights that it's not always straightforward.

With autosomal dominant conditions, yes, an affected parent has a 50 -50 chance of passing it on.

Boy or girl, doesn't matter.

Right.

But those exceptions you mentioned, the user came down to two key concepts.

Reduced penetrance and variable expressivity.

Okay, break those down for us.

What's the difference?

Okay.

So, reduced penetrance is your skip scenario.

Someone inherits the dominant faulty gene,

but they show zero signs of the disorder, nothing.

Oh, so they have the gene, but not the condition.

Exactly.

It's like, they have the genetic potential, but it just doesn't manifest.

Then there's variable expressivity.

Here, the gene is expressed, the person does have the condition,

but how it shows up can vary hugely.

Ah, so like mild in one person, severe in another.

Precisely.

A great example is polydactyly having extra fingers or toes.

One family member might have a fully formed extra finger, while their relative might just have a tiny skin tag on their toe.

Same gene, different expression.

That makes sense.

So, penetrance is if it shows up, expressivity is how it shows up.

That must be critical for predictions.

Let's make this concrete with a couple of examples.

Marfan syndrome, that's a dominant one, right?

Yes, a classic example.

It's a connective tissue disorder caused by a defect in a protein called fibrillin I.

And since fibrillin is like everywhere in your connective tissue.

The effects are widespread.

Absolutely.

You get the characteristic really long limbs, long fingers, they call it arachnidactyly, like spider fingers, hypermobile joints too, spinal curves, chest deformities.

But what's the most critical thing for management?

The heart.

Specifically the aorta, the big artery leaving the heart.

It gets progressively weaker and wider.

And the biggest danger, the life -threatening risk, is that it could suddenly tear or rupture.

That's the number one focus.

Okay.

And the second dominant example, neurofibromatosis or NF1.

What's the defect there?

NF1 is caused by a mutation in a tumor suppressor gene.

This leads to, well, neurogenic tumors.

But the diagnosis often relies on some very visible signs.

Like what?

The big one is seeing six or more of those flat brownish skin spots, the cafe au lait spots.

They need to be fairly large, over 1 .5 centimeters usually.

Okay.

Plus you often see those soft fleshy growths on the skin, the neurofibromas themselves.

And unfortunately, NF1 also carries increased risks for learning dyssopathies and developing certain malignant cancers later on.

All right.

Now let's shift gears to autosomal recessive disorders.

The pattern here is quite different, isn't it?

Totally different.

For a recessive condition to show up, the person has to inherit two copies of the faulty gene, one from each parent.

So they have to be homozygous.

Which means the parents are usually just carriers, right?

They have one copy but are healthy.

Exactly right.

The typical situation is two parents, both heterozygous carriers, both perfectly healthy.

For each pregnancy they have, there's a very specific set of odds.

It's a 25 % chance the child will be affected, getting both faulty copies.

A 50 % chance the child will be an unaffected carrier, just like the parents.

And a 25 % chance the child will be completely unaffected, inheriting two normal copies.

And you mentioned these tend to have an earlier onset.

Generally, yes.

And often the symptoms are a bit more uniform compared to the variability we see in dominant disorders.

That early onset makes screening vital.

Let's look at PKU as a recessive example.

PKU, or phenylketonuria.

This is a metabolic disorder.

Basically, there's a deficiency in an enzyme called phenylalanine hydroxylase.

And what does that enzyme normally do?

It breaks down phenylalanine, an amino acid found in protein.

Without the enzyme, phenylalanine builds up to toxic levels in the body.

Leading to?

Severe intellectual disability, if it's not treated.

And the key here is urgency.

Newborn screening for PKU is universal now in many places.

If a baby tests positive, treatment, which is a very strict low -phenylalanine diet, has to start incredibly fast, like within the first 7 to 10 days of life.

Wow, that's a narrow window.

It is.

To prevent irreversible brain damage, it really shows the power of newborn screening.

Absolutely.

Okay, second recessive example, Tay -Sachs disease.

This one is devastating.

It truly is.

Tay -Sachs is a lysosomal storage disease.

The lysosomes are like the cells of recycling centers.

And in Tay -Sachs, they fail to break down a fatty substance called GM2 ganglioside.

So it just accumulates?

Yes.

Primarily in the neurons, the nerve cells of the brain, the retina, and the eye.

Infants seem normal at first, but then around 6 to 10 months, they start declining rapidly.

Progressive neurological deterioration, muscle weakness, seizures.

Is there a specific diagnostic sign doctors look for?

Yes, a very specific one.

An eye exam reveals a cherry red spot on the macula, which is part of the retina.

That's a hallmark sign.

And there's a population link here, too.

There is.

Tay -Sachs has a significantly higher incidence in people of Ashkenazi Jewish descent.

This is due to what's called a founder effect in that population's genetic history.

Okay.

So that covers dominant and recessive.

What about genes on the sex chromosomes, X -linked recessive traits?

Right.

So here, the inheritance pattern is tied to the X and Y chromosomes.

The key takeaway is the sex difference in who gets affected.

How does that work?

Typically, the faulty gene is on the X chromosome.

An unaffected mother carrying one faulty X and one normal X can pass it on.

Her sons have a 50 % chance of getting the faulty X and being affected, since they only have one X.

Her daughters have a 50 % chance of getting the faulty X and becoming carriers like her.

And if father is affected?

An affected father will always pass his faulty X chromosome to all of his daughters, making them carriers.

But he passes his Y chromosome to his sons, so none of the sons will inherit the condition from him.

Makes sense.

Okay.

So we've covered these single gene sort of Mendelian patterns, but sometimes the problem isn't a single gene.

It's much bigger, right?

Like the whole chromosome count is off.

Exactly.

We move from specific gene changes to these larger scale structural issues.

The general term for an abnormal number of chromosomes is aneuploidy.

Aneuploidy.

Too many or too few.

And what causes that usually?

The most common cause is an error during meiosis, the process that makes sperm and eggs.

It's called nondisjunction.

Basically, a pair of chromosomes fails to separate properly.

So the resulting egg or sperm ends up with an extra chromosome or one missing.

Precisely.

Instead of the usual 23 chromosomes, it might have 24 or 22.

If that cell is involved in fertilization, the resulting embryo will have 47 or 45 chromosomes instead of the normal 46.

And the most common aneuploidy that results in a live birth is trisomy 21 or Down syndrome.

That's right.

Trisomy 21 means there are three copies of chromosome 21 instead of the usual two.

In about 95 % of cases, this is caused by that nondisjunction error we just talked about.

There's also a rarer form, maybe 4 % or so, caused by something called a Robertsonian translocation.

In this case, the person technically has 46 chromosomes overall.

But the extra chromosome 21 material is actually stuck onto another chromosome, often chromosome 14.

So genetically, they still have the material of three chromosome 21s.

Interesting distinction.

And there's a known risk factor for the nondisjunction type.

Yes.

A very clear correlation with advanced maternal age.

The risk of having a child with trisomy 21 due to nondisjunction increases significantly as the mother gets older, particularly after age 35.

And Down syndrome has some very recognizable physical features, right?

How would you describe them for someone just listening?

Sure.

You often see a somewhat flatter facial profile, a small nose, maybe the tongue protrudes a bit because the oral cavity is smaller.

The eyes often have an upward slant, partly due to extra skin folds called epicanthal folds at the inner corners.

And another classic sign many people know is the single deep crease across the palm of the hand, sometimes called a simian crease.

Plus, there are often associated health issues like heart defects and an increased risk of leukemia.

Now you mentioned aneuploidy of the autosomes, like chromosome 21.

What about aneuploidy involving the sex chromosomes X and Y?

Are those conditions as severe?

Generally, no.

Numeric disorders involving sex chromosomes tend to be much better tolerated, often with less severe consequences than having an extra or missing autosome.

Why is that?

Two main reasons.

First, the Y chromosome actually carries relatively few genes compared to the X or the autosomes.

Second, there's a natural mechanism in females called X inactivation.

Right, where one X gets shut down.

Exactly.

Early in embryonic development, in every cell of a female, one of the two X chromosomes is randomly inactivated, becoming this condensed structure called a bar body.

This basically balances the dose of X -linked genes between males X, Y and females X, X.

And it also helps compensate if there's an extra X chromosome present.

Ah, okay.

So that explains why conditions like Turner syndrome and Kleinfilter syndrome, while significant, are compatible with life.

Tell us about those.

Sure.

Turner syndrome affects females and occurs when they have only one X chromosome,

The classic features are short stature, a distinctive webbed appearance of the neck, and often heart defects, like a bicuspid aortic valve.

And developmentally?

The most significant issue is ovarian failure.

They're born with ovaries, but the eggs, the oocytes, are lost very early on, leading to infertility and lack of puberty without hormone treatment.

Okay.

And Kleinfilter syndrome?

Kleinfilter syndrome affects males who have an extra X chromosome, 47 ,000 XY.

They tend to be with disproportionately long arms and legs.

The main issue is hypogonadism underdeveloped tests, low testosterone, which leads to infertility and often some breast enlargement called gynecomastia.

There can also be some degree of language impairment or learning difficulties.

All right.

So we've done single genes, we've done whole chromosomes.

What about things that seem to be a mix of both genes and environment, multifactorial disorders?

Yes, this is a really important category.

Unlike single gene Mendelian disorders, these don't follow simple inheritance patterns.

They result from the complex interplay of multiple genes, each having a small effect plus environmental factors.

So it's genes plus something else triggers it?

Kind of, yeah.

Or multiple small genetic variations plus environmental influences add up to cross the threshold.

A very common example is cleft lip and cleft palate.

How does that happen?

During fetal development, around day 35, different parts of the face need to grow and fuse together properly.

If this process fails for some reason, you can get a cleft or split in the lip, the palate, at the roof of the mouth or both.

And the inheritance risk?

It's complex because multiple genes are involved.

But what we do know is that the recurrence risk is significantly higher for first degree relatives, parents, siblings, children of someone affected.

And importantly, the risk is highest for the same type of defect.

Meaning if a parent had a cleft lip, the child is at higher risk for cleft lips specifically.

Generally, yes.

More so than for, say, a heart defect.

Management obviously involves surgery, often multiple surgeries, plus challenges with feeding initially and potentially speech therapy later on.

Okay.

One last genetic category before we move to purely environmental causes.

Mitochondrial gene disorders.

What's the absolute must -know fact here?

The inheritance pattern.

Mitochondrial DNA or MTDNA is inherited exclusively from the mother.

Only the mother.

Why?

Because mitochondria, the energy powerhouses of the cell, are located in the cytoplasm.

The egg cell contributes almost all the cytoplasm, including mitochondria, to the zygote.

Sperm contribute basically just their nucleus, very few, if any, mitochondria make it in.

Got it.

So mitochondrial disorders pass down the maternal line.

Correct.

And since mitochondria are crucial for energy production, these disorders often with high energy demands the hardest like muscles and the nervous system.

So you see a lot of neuromuscular symptoms.

Fascinating.

Okay.

That wraps up the genetic side.

Let's move to our second major pillar.

Environmental influences.

Purely external factors causing problems.

You mentioned timing is crucial here.

Absolutely critical.

There's a specific time frame known as the period of vulnerability.

When is that?

It's roughly from day 15 to day 60 after conception.

This is the period of organogenesis when all the major organ systems are forming.

So exposure to harmful agents during this window is the most dangerous.

By far, for causing major structural birth defects.

Before day 15, exposure is often an all -or -none effect.

It might cause such severe damage the pregnancy doesn't continue.

After day 60, most major structures are formed, so the risk of gross anomalies decreases, although damage, especially to the developing brain, can still occur.

And the agents that cause these problems are called teratogens.

Yes.

A teratogenic agent is any chemical, physical, or biological agent that can cause abnormalities in the developing fetus.

Let's talk examples.

What are some key teratogens?

The historical example everyone learns about is thalidomide,

a sedative prescribed in the late 50s, early 60s.

Caused horrific limb defects.

Yes.

Focumelia severely shortened flipper -like limbs.

It tragically highlighted the danger of untested drugs during pregnancy.

Today, the FDA has pregnancy categories for drugs.

Category A is considered safest.

Category X is absolutely contraindicated.

What about physical agents, like radiation?

High doses of radiation are definitely teratogenic, especially during that critical period.

They can cause things like microcephaly, small head, and intellectual disability.

And chemicals or drugs we still worry about today?

Alcohol is a huge one.

Fetal alcohol syndrome, or FAS.

Why is alcohol particularly bad?

Does it only matter during that 15 to 60 -day window?

No, and that's crucial.

Alcohol is lipid -soluble, meaning it crosses the placenta very easily and reaches the fetus.

And its harmful effects aren't limited to organogenesis.

Alcohol exposure can damage the fetus throughout the entire pregnancy.

Affecting growth and brain development continuously.

Yes.

FAS has a characteristic pattern of facial features doctors look for.

Small eye openings, palpebral fissures, a very thin upper lip, thin vermilion border, and a smooth or flattened that vertical groove between the nose and upper lip.

Plus, growth restriction and significant neurodevelopmental problems.

What about infections?

Can germs cross the placenta and cause harm?

Absolutely.

There's a group of infectious agents known to be teratogenic,

often summarized by the acronym TORCH.

TORCH.

What does that stand for?

T is for toxoplasmosis, a parasitic infection.

O is for other infections, like syphilis, varicella zoster.

R is for rubella, German measles.

C is for cytomegalovirus, CMV.

And H is for herpes simplex virus.

These are some of the most frequent infectious causes of fetal anomalies.

That's healthful mnemonic.

Now one more environmental factor, but this one is about deficiency, not exposure.

Folic acid.

Yes.

This is a major public health success story, actually.

We know that insufficient folic acid intake before conception and in early pregnancy significantly increases the risk of neural tube defects, or NTDs.

Like spina bifida.

Exactly.

Spina bifida, where the spinal cord doesn't close properly, and encephaly, a severe defect where parts of the brain and skull are missing.

Research clearly show that folic acid supplementation dramatically reduces the risk.

So what's the recommendation?

The standard recommendation is for all women of childbearing age, not just those planning pregnancy, to take 400 micrograms, .4 milligrams of folic acid daily.

Because many pregnancies are unplanned, and the neural tube closes very early, often before a woman even knows she's pregnant.

That makes sense.

Ensure the levels are adequate before that critical window even starts.

Precisely.

Okay.

This understanding of genetic and environmental risks leads us logically to our final section.

Diagnosis and counseling.

Why is prenatal screening and diagnosis so important now?

Well, there are several key reasons.

It allows for genetic assessment to understand the nature of a potential problem.

It helps determine the specific risks involved.

For parents, it can help alleviate anxiety by providing information.

Even if the news is difficult.

And practically.

Practically, it allows for planning.

In some rare cases, it might open the door for potential intrauterine treatments.

More commonly, it helps the medical team prepare for the birth, knowing if a baby might need immediate specialized care, surgery, or specific support right after delivery.

Let's start with the non -invasive methods.

What can be done without risk to the fetus?

The workhorse is ultrasonography.

Ultrasound uses sound waves to create images of the fetus.

It's fundamental for checking fetal growth, position, and anatomy.

You can often visualize major structural anomalies, heart defects, limb abnormalities, spina bifida, cleft lipolate.

And there are newer ultrasound techniques, too?

Yes.

Particularly in the first trimester, there's the new -shell translucency screening.

This measures the fluid -filled space at the back of the fetal neck.

A thicker space is associated with an increased risk for certain chromosomal abnormalities, especially Down syndrome.

Okay.

What else besides imaging?

Maternal serum markers.

This involves blood tests on the mother.

The quad screen is common, measuring levels of four substances in the mother's blood.

AFP, alpha -fetal protein,

ACG, estriol, and an hebin A.

Sometimes a fifth marker, PPPA, is included earlier.

And what do these levels tell you?

The specific pattern of these marker levels, combined with the mother's age, is used to calculate the statistical risk estimate for Trisomy 21, Trisomy 18, and Trisomy 13.

It's important to stress these are screening tests.

They estimate risk.

They don't provide a definitive diagnosis.

So if a screening test comes back high -risk, you need a diagnostic test for confirmation.

Exactly.

And diagnostic tests are typically invasive, meaning they involve obtaining fetal cells to analyze the chromosomes directly doing a karyotype.

What are the main invasive procedures?

There are three primary ones.

Amniocentesis involves using a needle to withdraw a small amount of amniotic fluid surrounding the fetus.

This fluid contains fetal cells.

It's usually done after 15 weeks of gestation.

Okay.

Chorionic villus sampling, or CVS, obtains a tiny sample of tissue from the placenta, the chorionic villi.

This can be done earlier than amnio, typically between 10 and 13 weeks.

There might be a slightly higher risk of complications if done too early.

And the third?

Percutaneous umbilical cord blood sampling, or PUBS, sometimes called corticentesis.

This involves guiding a needle into a blood vessel in the umbilical cord to get a sample of fetal blood.

It's usually reserved for situations where rapid results are needed later in pregnancy, or if amnio or CVS failed or were impossible.

Right.

Each provides actual fetal cells for definitive genetic analysis.

Correct.

Karyotyping, f -ishane analysis, microarray.

You can get a clear picture of the chromosomes and specific gene sequences if needed.

Wow, okay.

That was an incredibly thorough deep dive.

Let's try to synthesize this for everyone listening.

We've really covered three huge areas influencing congenital defects.

First, those predictable, yet sometimes complex, single -gene Mendelian patterns.

We saw examples like Marfan syndrome, where the big danger is that aortic rupture.

And PSAU, where that super early dietary fix is non -negotiable.

Right, the rules of inheritance, but also the nuances like penetrance and expressivity.

Then second, we looked at the larger scale chromosomal problems in a porty, with Trisomy 21 Down syndrome being the most common.

And we learned why sex chromosome issues like Turner syndrome are often better tolerated.

Because of X inactivation and the Y having fewer genes.

And third, we covered the crucial impact of the environment, especially during that critical to 60 -day window of organ building, highlighting teratogens like alcohol and infections, and the protective role of folic acid.

Absolutely.

Understanding these different origins, genetic, chromosomal, environmental, and sometimes multifactorial is key.

And the advances in screening and diagnosis have really transformed how we approach these situations in healthcare.

Yeah, the ability to know more earlier provides certainty and allows for preparation, as you said.

It does.

Which, when you think about it, brings up a pretty interesting point.

Which is?

Well, connecting this back to the bigger picture of modern medicine.

So what does this all mean for practice, for families?

We've talked about how prenatal diagnosis can allow for treatments or birth planning.

But thinking back to what you said about reduced penetrance and variable expressivity,

even when a genetic test confirms a mutation, like in a dominant disorder, the severity can still be unpredictable, right?

You might know the gene is there, but not exactly how bad the outcome will be.

That's often true, yes.

So how does knowing the genetic diagnosis before birth actually shape the immediate medical decisions and the family's planning when there's still that element of uncertainty about the ultimate severity or the full range of symptoms?

It seems like a really complex, ethical, and practical space.

It absolutely is.

That tension between the power of prediction and the inherent biological uncertainty.

That's really at the heart of genetic counseling today.

It's something clinicians and families navigate constantly.

Thank you truly for diving deep through these fundamental concepts with us today.

And thank you everyone for listening to this deep dive from the Last Minute Lecture Team.

We hope this breakdown was helpful.